Home
Caligan Partners reported a 5.9% stake in Avalo Therapeutics AVTX · 3,163,866 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.9%
- Last report
- 7.2% · filed 26/05/15
- Shares held
- 3,163,866 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Caligan Partners
- Event date
- 26/06/30
- Filed
- 26/08/14
5.9% stake · −1.3pp from the last report
- Stake
- 5.9%
- Last report
- 7.2%
- Since last report
- −1.3pp
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Caligan Partners's other 5% stake reports
- Caligan Partners
5% stakeSAB Biotherapeutics
5% stakeSAB Biotherapeutics
SABS
8.8% stake
7,967,207 sh
8.8% stake
Filed 08/14
- Caligan Partners
5% stakeOpus Genetics
5% stakeOpus Genetics
IRD
7.3% stake
6,077,084 sh
7.3% stake
Filed 08/14
- Caligan Partners
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
2.4% stake
629,467 sh
2.4% stake
Filed 08/14
- Caligan Partners
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
5.9% stake
469,998 sh
5.9% stake
Filed 08/14
- Caligan Partners
5% stakeSAB Biotherapeutics
5% stakeSAB Biotherapeutics
SABS
10.4% stake
7,967,207 sh
10.4% stake
Filed 05/15
